Literature DB >> 10199780

Follicle-stimulating hormone-inhibin B interactions during the follicular phase of the primate menstrual cycle revealed by gonadotropin-releasing hormone antagonist and antiestrogen treatment.

H M Fraser1, N P Groome, A S McNeilly.   

Abstract

The aim was to determine the pattern of inhibin A and inhibin B secretion during the ovulatory cycle of the macaque and to explore the effects of manipulating follicular phase FSH on inhibin B secretion by: 1) blocking the early follicular phase rise in FSH with GnRH antagonist treatment; 2) administering FSH in GnRH antagonist-treated animals; and 3) preventing the midfollicular phase decline in FSH by a specific antiestrogen. Treatment with GnRH antagonist, starting on day 25 of the cycle, abolished the early follicular phase rise in FSH and the associated increase in inhibin B. The same treatment, followed by exogenous FSH, restored the secretion of inhibin B. Treatment with antiestrogen, commencing during the midfollicular phase, induced a supraphysiological rise in FSH, followed by a marked stimulation of inhibin B and estradiol secretion. Despite continued antiestrogen treatment, FSH secretion declined before peak values of inhibin B and estradiol were attained, implying a potential endocrine role for inhibin B, in addition to estradiol, in the negative feedback regulation of FSH. These results show that follicular phase FSH is the major stimulus for inhibin B secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199780     DOI: 10.1210/jcem.84.4.5586

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Activin modulates the transcriptional response of LbetaT2 cells to gonadotropin-releasing hormone and alters cellular proliferation.

Authors:  Hao Zhang; Janice S Bailey; Djurdjica Coss; Bo Lin; Rie Tsutsumi; Mark A Lawson; Pamela L Mellon; Nicholas J G Webster
Journal:  Mol Endocrinol       Date:  2006-06-13

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

3.  Ovulation block by Pueraria mirifica: a study of its endocrinological effect in female monkeys.

Authors:  Hataitip Trisomboon; Suchinda Malaivijitnond; Gen Watanabe; Kazuyoshi Taya
Journal:  Endocrine       Date:  2005-02       Impact factor: 3.633

4.  Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment.

Authors:  Eirini Bouzoni; Nikolaos Perakakis; Christos S Mantzoros
Journal:  Metabolism       Date:  2020-10-10       Impact factor: 8.694

5.  Physiology and Endocrinology of the Ovarian Cycle in Macaques.

Authors:  Gerhard F Weinbauer; Marc Niehoff; Michael Niehaus; Shiela Srivastav; Antje Fuchs; Eric Van Esch; J Mark Cline
Journal:  Toxicol Pathol       Date:  2008-12       Impact factor: 1.902

Review 6.  Female reproductive system and bone.

Authors:  Bart L Clarke; Sundeep Khosla
Journal:  Arch Biochem Biophys       Date:  2010-07-14       Impact factor: 4.013

7.  Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women.

Authors:  Marcus A Rosencrantz; Deborah S Wachs; Mickey S Coffler; Pamela J Malcom; Michael Donohue; R Jeffrey Chang
Journal:  Hum Reprod       Date:  2009-10-22       Impact factor: 6.918

8.  Extraovarian gonadotropin negative feedback revealed by aromatase inhibition in female marmoset monkeys.

Authors:  Marissa Kraynak; Matthew T Flowers; Robert A Shapiro; Amita Kapoor; Jon E Levine; David H Abbott
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-05       Impact factor: 4.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.